Whats New

Scleroderma is a rare disease that leads to fibrosis or hardening of the skin and connective tissue. The disease varies from person to person in terms of extent, its patterns of skin and organ involvement, and the rate of progression. It can also affect the lungs, kidneys, heart and other internal organs. In the U.S., approximately 100,000 people have scleroderma.

Atrophic papulosis or Degos disease (DD) has 2 variants: 1) a more common, limited, cutaneous type, which can be referred to as benign atrophic papulosis (BAP) and 2) a severe systemic

C.C. Zouboulis,* A. Theodoridis, M. Brunner, C.M. Magro Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Theodore Fontane Medical University of Brandenburg, Dessau, Germany Freiburg Veins Center, Freiburg, Germany Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA *Correspondence: C.C. Zouboulis. E-mail: christos.zouboulis@klinikum-dessau.de Abstract Background Atrophic papulosis is a [...]

Malignant and benign forms of atrophic papulosis (Kohlmeier € –Degos disease): systemic involvement determines the prognosis A. Theodoridis,1,2 A. Konstantinidou,3 E. Makrantonaki1,4 and C.C. Zouboulis1 Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Auenweg 38, 06847 Dessau, Germany Freiburg Vein Center, Z€ahringer Straße 14, 79108 Freiburg, Germany 3 Institute of Mathematics, Humboldt University [...]

Scleroderma is a rare disease that leads to fibrosis or hardening of the skin and connective tissue. The disease varies from person to person in terms of extent, its patterns of skin and organ involvement, and the rate of progression. It can also affect the lungs, kidneys, heart and other internal organs. In the U.S., approximately 100,000 people have scleroderma.

Atrophic papulosis or Degos disease (DD) has 2 variants: 1) a more common, limited, cutaneous type, which can be referred to as benign atrophic papulosis (BAP) and 2) a severe systemic

C.C. Zouboulis,* A. Theodoridis, M. Brunner, C.M. Magro Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Theodore Fontane Medical University of Brandenburg, Dessau, Germany Freiburg Veins Center, Freiburg, Germany Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA *Correspondence: C.C. Zouboulis. E-mail: christos.zouboulis@klinikum-dessau.de Abstract Background Atrophic papulosis is a [...]

Malignant and benign forms of atrophic papulosis (Kohlmeier € –Degos disease): systemic involvement determines the prognosis A. Theodoridis,1,2 A. Konstantinidou,3 E. Makrantonaki1,4 and C.C. Zouboulis1 Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Auenweg 38, 06847 Dessau, Germany Freiburg Vein Center, Z€ahringer Straße 14, 79108 Freiburg, Germany 3 Institute of Mathematics, Humboldt University [...]

The Ann Steffens Scleroderma Research Foundation is holding a dinner in honor of Dr Shapiro as the National Scleroderma Foundation Doctor of the Year on October 28, 2017 at Riverstone Manor, Scotia NY. Proceeds will benefit the research foundation’s mission to support research toward treatment and cure of Scleroderma, Degos Disease and related disorders. Plan […]

The first International Degos Disease Symposium is scheduled to occur Friday, April 27th, 2018, at the NIH Clinical Center Building 10 in the FAES Conference Rooms 3 & 4 on the National Institutes of Health (NIH) Campus in Bethesda, Maryland. This Symposium will provide a forum for clinicans and patients to come together in an environment […]

As the disease progressed. The lesions became extremely florid and inflamed. Some ulcerated and became badly infected.

Vanessa's lesion photos 2011